Back to search
FDAFDA · Food and drugs·Recall number Z-2580-2020

CMExpress Microbore Sets, REF: A120-161C

Published July 22, 2020 · Recall initiated: June 16, 2020

Summary

FDA records medical device Class I recall Z-2580-2020, published July 22, 2020 and initiated June 16, 2020. Recalling firm: CME America, LLC; Status: Terminated; Reported quantity: 50122; Lot: All lots within expiry. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
CME America, LLC
Distributor
U.S: CA, IN, LA, MO, FL, IL, ME, MN, CO, VA, OK, NE, GA, AL, KY, IA, MS, ID, TX, SC, OH, SD, NV, MI, WY, NC, PA, TN, KS, NJ, OR, AR, NM, MA, NY, DC, RI, MD, WA, WI, AZ, NH, UT, HI, AK, MT, ND, VT, CT. OUS (Foreign): Canada, UK
Lot
All lots within expiry
Risk classification
Class I
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was CMExpress Microbore Sets, REF: A120-161C recalled?

Yes. FDA published recall Z-2580-2020 on July 22, 2020. Reported hazard: Infusion administration sets may have a delivery inaccuracy over plus/minus 13%, ranging from minus 42.8% to plus 17.5%. Use of the infusion pump system could cause over-infusion or under-infusion of therapy

What should I do if I have this product?

Voluntary: Firm initiated · Letter